vs
Side-by-side financial comparison of Taysha Gene Therapies, Inc. (TSHA) and Twin Vee PowerCats, Co. (VEEE). Click either name above to swap in a different company.
Taysha Gene Therapies, Inc. is the larger business by last-quarter revenue ($5.5M vs $3.0M, roughly 1.8× Twin Vee PowerCats, Co.). Twin Vee PowerCats, Co. runs the higher net margin — -85.6% vs -507.8%, a 422.2% gap on every dollar of revenue. On growth, Taysha Gene Therapies, Inc. posted the faster year-over-year revenue change (171.3% vs 60.4%). Over the past eight quarters, Taysha Gene Therapies, Inc.'s revenue compounded faster (26.8% CAGR vs -24.3%).
Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company specializing in developing adeno-associated virus (AAV)-based gene therapies for rare monogenic central nervous system disorders with high unmet medical needs. Its core pipeline targets serious life-threatening neurological conditions, with primary operations and market focus across North America and European regions.
Twin Vee PowerCats Co. is a leading manufacturer of high-performance recreational power catamaran boats. The company offers a diverse lineup of catamaran models suited for leisure cruising, fishing, water sports, and commercial marine use, serving customers primarily across North America, with a growing distribution network in global coastal markets.
TSHA vs VEEE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.5M | $3.0M |
| Net Profit | $-27.9M | $-2.6M |
| Gross Margin | — | 3.7% |
| Operating Margin | -516.0% | -87.7% |
| Net Margin | -507.8% | -85.6% |
| Revenue YoY | 171.3% | 60.4% |
| Net Profit YoY | -48.3% | -119.0% |
| EPS (diluted) | $-0.08 | $-1.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.5M | $3.0M | ||
| Q3 25 | $0 | $3.4M | ||
| Q2 25 | $2.0M | $4.8M | ||
| Q1 25 | $2.3M | $3.6M | ||
| Q4 24 | $2.0M | $1.9M | ||
| Q3 24 | $1.8M | $2.9M | ||
| Q2 24 | $1.1M | $4.3M | ||
| Q1 24 | $3.4M | $5.3M |
| Q4 25 | $-27.9M | $-2.6M | ||
| Q3 25 | $-32.7M | $-2.8M | ||
| Q2 25 | $-26.9M | $-1.7M | ||
| Q1 25 | $-21.5M | $-1.6M | ||
| Q4 24 | $-18.8M | $-1.2M | ||
| Q3 24 | $-25.5M | $-3.0M | ||
| Q2 24 | $-20.9M | $-4.5M | ||
| Q1 24 | $-24.1M | $-2.3M |
| Q4 25 | — | 3.7% | ||
| Q3 25 | — | -1.3% | ||
| Q2 25 | — | 13.8% | ||
| Q1 25 | — | 14.9% | ||
| Q4 24 | — | -57.6% | ||
| Q3 24 | — | -5.0% | ||
| Q2 24 | — | 4.7% | ||
| Q1 24 | — | 5.3% |
| Q4 25 | -516.0% | -87.7% | ||
| Q3 25 | — | -81.0% | ||
| Q2 25 | -1347.1% | -35.2% | ||
| Q1 25 | -930.5% | -46.5% | ||
| Q4 24 | -985.8% | -224.9% | ||
| Q3 24 | -1448.4% | -107.3% | ||
| Q2 24 | -1915.4% | -107.7% | ||
| Q1 24 | -713.3% | -48.2% |
| Q4 25 | -507.8% | -85.6% | ||
| Q3 25 | — | -80.4% | ||
| Q2 25 | -1353.6% | -34.8% | ||
| Q1 25 | -935.2% | -44.6% | ||
| Q4 24 | -929.0% | -62.7% | ||
| Q3 24 | -1427.5% | -103.7% | ||
| Q2 24 | -1882.0% | -104.4% | ||
| Q1 24 | -705.4% | -44.3% |
| Q4 25 | $-0.08 | $-1.19 | ||
| Q3 25 | $-0.09 | $-1.23 | ||
| Q2 25 | $-0.09 | $-0.87 | ||
| Q1 25 | $-0.08 | $-1.08 | ||
| Q4 24 | $-0.07 | $-3.51 | ||
| Q3 24 | $-0.10 | $-2.64 | ||
| Q2 24 | $-0.09 | $-3.09 | ||
| Q1 24 | $-0.10 | $-1.77 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $319.8M | $1.4M |
| Total DebtLower is stronger | — | $499.9K |
| Stockholders' EquityBook value | $246.9M | $13.5M |
| Total Assets | $343.3M | $16.2M |
| Debt / EquityLower = less leverage | — | 0.04× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $319.8M | $1.4M | ||
| Q3 25 | $297.3M | $2.7M | ||
| Q2 25 | $312.8M | $6.0M | ||
| Q1 25 | $116.6M | $4.9M | ||
| Q4 24 | $139.0M | $7.5M | ||
| Q3 24 | $157.7M | $11.1M | ||
| Q2 24 | $172.7M | $14.9M | ||
| Q1 24 | $124.0M | $17.1M |
| Q4 25 | — | $499.9K | ||
| Q3 25 | — | $499.9K | ||
| Q2 25 | — | $499.9K | ||
| Q1 25 | — | $499.9K | ||
| Q4 24 | — | $499.9K | ||
| Q3 24 | — | $499.9K | ||
| Q2 24 | — | $499.9K | ||
| Q1 24 | — | $499.9K |
| Q4 25 | $246.9M | $13.5M | ||
| Q3 25 | $219.0M | $15.9M | ||
| Q2 25 | $248.7M | $18.6M | ||
| Q1 25 | $55.1M | $17.7M | ||
| Q4 24 | $71.5M | $19.2M | ||
| Q3 24 | $88.8M | $17.4M | ||
| Q2 24 | $108.9M | $19.6M | ||
| Q1 24 | $53.8M | $22.3M |
| Q4 25 | $343.3M | $16.2M | ||
| Q3 25 | $316.6M | $18.9M | ||
| Q2 25 | $333.3M | $22.4M | ||
| Q1 25 | $138.4M | $23.6M | ||
| Q4 24 | $160.4M | $25.9M | ||
| Q3 24 | $180.2M | $30.1M | ||
| Q2 24 | $200.4M | $33.8M | ||
| Q1 24 | $153.0M | $36.5M |
| Q4 25 | — | 0.04× | ||
| Q3 25 | — | 0.03× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.03× | ||
| Q2 24 | — | 0.03× | ||
| Q1 24 | — | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-26.7M | $-1.7M |
| Free Cash FlowOCF − Capex | — | $-1.9M |
| FCF MarginFCF / Revenue | — | -62.5% |
| Capex IntensityCapex / Revenue | — | 4.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-9.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-26.7M | $-1.7M | ||
| Q3 25 | $-24.2M | $-2.6M | ||
| Q2 25 | $-20.2M | $-745.6K | ||
| Q1 25 | $-22.0M | $-1.7M | ||
| Q4 24 | $-18.3M | $-2.3M | ||
| Q3 24 | $-21.6M | $-2.4M | ||
| Q2 24 | $-21.5M | $-482.1K | ||
| Q1 24 | $-19.8M | $-1.7M |
| Q4 25 | — | $-1.9M | ||
| Q3 25 | $-24.3M | $-3.1M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-2.6M | ||
| Q4 24 | $-18.3M | $-3.6M | ||
| Q3 24 | $-21.6M | $-3.7M | ||
| Q2 24 | $-21.7M | $-2.2M | ||
| Q1 24 | $-19.9M | $-3.7M |
| Q4 25 | — | -62.5% | ||
| Q3 25 | — | -91.2% | ||
| Q2 25 | — | -30.6% | ||
| Q1 25 | — | -71.0% | ||
| Q4 24 | -905.5% | -192.8% | ||
| Q3 24 | -1210.9% | -128.8% | ||
| Q2 24 | -1951.9% | -51.0% | ||
| Q1 24 | -584.5% | -70.9% |
| Q4 25 | — | 4.6% | ||
| Q3 25 | — | 14.0% | ||
| Q2 25 | — | 14.9% | ||
| Q1 25 | — | 22.9% | ||
| Q4 24 | 0.1% | 68.8% | ||
| Q3 24 | 2.0% | 45.8% | ||
| Q2 24 | 18.1% | 39.9% | ||
| Q1 24 | 4.1% | 37.7% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
